Knowing the central role of c-Myc in proliferation and malignant transformation of human and animal cells [22] and the growth inhibitory effect of JQ1, it is tempting to conclude that targeting the BET-family of proteins represents an exciting novel approach to treat breast cancer. The gene discussed is MYC; the disease is breast carcinoma.